Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs

Conclusions: Liver stiffness decrease was significant as early as 12 weeks after the end of treatment. Patients with diabetes and advanced liver disease are at higher risk of developing non-regressive fibrosis and hepatocellular carcinoma even after successful treatment.PMID:33652777 | DOI:10.3390/medicina57030210

Source: Medicina (Kaunas) - March 3, 2021 Category: Universities & Medical Training Authors: Martynas Ridziauskas Birut ė Zablockienė Ligita Jan čorienė Art ūras Samuilis Rolandas Zablockis Au šrinė Jackevičiūtė Source Type: research